Update on psychiatric genetics

Genetics in Medicine

Volumn 9, Issue 6, 2007, Pages 332-340

  Züchner, Stephan ^a,d   Roberts, Sushma T ^a,c   Speer, Marcy C ^b   Beckham, Jean C ^a,b,c  

^a Veterans Affairs Mid Atlantic Mental Illness Research Education and Clinical Center   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c DURHAM VA MEDICAL CENTER   (United States)

^d UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Association study; Complex disease; Linkage analysis; Psychiatric genetics

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; BRAIN DERIVED NEUROTROPHIC FACTOR; CATECHOL METHYLTRANSFERASE; DEXTRO AMINO ACID OXIDASE; DOPAMINE 2 RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE BETA MONOOXYGENASE; NEU DIFFERENTIATION FACTOR; PHOSPHODIESTERASE IV; PROLINE DEHYDROGENASE; RGS4 PROTEIN; SEROTONIN TRANSPORTER;

ANXIETY DISORDER; CHROMOSOME ABERRATION; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; GENE IDENTIFICATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC RISK; GENETIC VARIABILITY; GENOME; HEREDITY; HIGH THROUGHPUT SCREENING; HUMAN; MENTAL DISEASE; METABOLOMICS; MOOD DISORDER; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSESSIVE COMPULSIVE DISORDER; POSTTRAUMATIC STRESS DISORDER; REVIEW; REWARD; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; SUBSTANCE ABUSE;

EID: 34250737336     PISSN: 10983600     EISSN: None     Source Type: Journal    
DOI: 10.1097/GIM.0b013e318065a9fa     Document Type: Review

References (130)

1. Insel TR, Quirion R. Psychiatry as a clinical neuroscience discipline. JAMA 2005;294:2221-2224.
2. McHugh PR. Striving for coherence: psychiatry's efforts over classification. JAMA 2005;293:2526-2528.
3. Krishnan KR. Psychiatric disease in the genomic era: rational approach. Mol Psychiatry 2005;10:978-984.
4. Abelson JF, Kwan KY, O'Roak BJ, Baek DY, et al. Sequence variants in SLITRK1 are associated with Tourette's syndrome. Science 2005;310:317-320.
5. Züchner S, Cuccaro ML, Trans Viet KN, Cope H, et al. SLITRK1 mutations in Trichotillomania. Mol Psychiatry 2006;11:887-889.
6. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th edition. Washington, DC: American Psychiatric Association, 1994.
7. Kessler RC, Berglund P, Demler O, Jin R, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003;289:3095-3105.
8. Sullivan PF, Neale MC, Kendler KS. Genetic epidemiology of major depression: review and meta-analysis. Am J Psychiatry 2000;157:1552-1562.
9. Keck PEJ, McElroy SL, Arnold LM. Bipolar disorder. Med Clin North Am 2001;85:645-661.
10. McGuffin P, Rijsdijk F, Andrew M, Sham P, Katz R, Cardno A. The heritability of bipolar affective disorder and the genetic relationship to unipolar depression. Arch Gen Psychiatry 2003;60:497-502.
11. Shih RA, Belmonte PL, Zandi PP. A review of the evidence from family, twin and adoption studies for a genetic contribution to adult psychiatric disorders. Int Rev Psychiatry 2004;16:260-283.
12. Abkevich V, Camp NJ, Hensel CH, Neff CD, et al. Predisposition locus for major depression at chromosome. Am J Hum Genet 2003;73:1271-1281.
13. Dawson E, Parfitt E, Roberts Q, Daniels J, et al. Linkage studies of bipolar disorder in the region of the Darier's disease gene on chromosome 12q23-24.1. Am J Med Genet 1995;60:94-102.
14. Morissette J, Villeneuve A, Bordeleau L, Rochette D, et al. Genome-wide search for linkage of bipolar affective disorders in a very large pedigree derived from a homogeneous population in quebec points to a locus of major effect on chromosome 12q23-q24. Am J Med Genet 1999;88:567-587.
15. Fullerton J, Cubin M, Tiwari H, Wang C, et al. Linkage analysis of extremely discordant and concordant sibling pairs identifies quantitative-trait loci that influence variation in the human personality trait neuroticism. Am J Hum Genet 2003;72:879-890.
16. Holmans P, Zubenko GS, Crowe RR, DePaulo JR Jr, et al. Genomewide significant linkage to recurrent, early-onset major depressive disorder on chromosome 15q. Am J Hum Genet 2004;74:1154-1167.
17. Badner JA, Gershon ES. Meta-analysis of whole-genome linkage scans of biploar disorder and schizophrenia. Mol Psychiatry 2002;7:405-411.
18. Segurado R, Detera-Wadleigh SD, Levinson DF, Lewis CM, et al. Genome scan meta-analysis of schizophrenia and bipolar disorder. Part III. Bipolar disorder. Am J Hum Genet 2003;73:49-62.
19. Coppen A, Wood K. 5-Hydroxytryptamine in the pathogenesis of affective disorders. Adv Biochem Psychopharmacol 1982;34:249-258.
20. Kalia M. Neurobiological basis of depression: an update. Metabolism 2005;54 (5 Suppl 1):24-27.
21. Meltzer HY, Arora RC. Genetic control of serotonin uptake in blood platelets: a twin study. Psychiatry Res 1988;24:263-269.
22. Meltzer HY, Arora RC, Baber R, Tricou BJ. Serotonin uptake in blood platelets of psychiatric patients. Arch Gen Psychiatry 1981;38:1322-1326.
23. Lesch KP, Bengel D, Heils A, Sabol SZ, et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996;274:1527-1531.
24. Heils A, Teufel A, Petri S, Stober G, et al. Allelic variation of human serotonin transporter gene expression. J Neurochem 1996;66:2621-2624.
25. Caspi A, Sugden K, Moffitt TE, Taylor A, et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 2003;301:386-389.
26. Murphy DL, Li Q, Engel S, Wichems C, et al. Genetic perspectives on the serotonin transporter. Brain Res Bull 2001;56:487-494.
27. Bennett AJ, Lesch KP, Heils A, Long JC, et al. Early experience and serotonin transporter gene variation interact to influence primate CNS function. Mol Psychiatry 2002;7:118-122.
28. Hariri AR, Mattay VS, Tessitore A, Kolachana B, et al. Serotonin transporter genetic variation and the response of the human amygdala. Science 2002;297:400-403.
29. Cho HJ, Meira-Lima I, Cordeiro Q, Michelon L, et al. Population-based and family-based studies on the serotonin transporter gene polymorphisms and bipolar disorder: a systematic review and meta-analysis. Mol Psychiatry 2005;10:771-781.
30. Preisig M, Bellivier F, Fenton BT, Baud P, et al. Association between bipolar disorder and monoamine oxidase A gene polymorphisms: results of a multicenter study. Am J Psychiatry 2000;157:948-955.
31. Jones I, Craddock N. Candidate gene studies of bipolar disorder. Ann Med 2001;33:248-256.
32. Cases O, Seif I, Grimsby J, Gaspar P, et al. Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA. Science 1995;268:1763-1766.
33. Zhang X, Gainetdinov RR, Beaulieu JM, Sotnikova TD, et al. Loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression. Neuron 2005;45:11-16.
34. Zhang X, Beaulieu JM, Sotnikova TD, Gainetdinov RR, Caron MG. Tryptophan hydroxylase-2 controls brain serotonin synthesis. Science 2004;305:217.
35. Blakely RD. Overview: a rare opportunity or just one less reason to be depressed. Neuron 2005;48:701-702.
36. Zhou Z, Roy A, Lipsky R, et al. Haplotype-based linkage of tryptophan hydroxylase 2 to suicide attempt, major depression, and cerebrospinal fluid 5-hydroxyindoleacetic acid in 4 populations. Arch Gen Psychiatry 2005;62:1109-1118.
37. Sklar P, Gabriel SB, McInnis MG, Bennett P, et al. Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Mol Psychiatry 2002;7:579-593.
38. Neves-Pereira M, Mundo E, Muglia P, King N, Macciardi F, Kennedy JL. The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: evidence from a family-based association study. Am J Hum Genet 2002;71:651-655.
39. Geller B, Badner JA, Tillman R, Christian SL, Bolhofner K, Cook EHJ. Linkage disequilibrium of the brain-derived neurotrophic factor Val66Met polymorphism in children with a prepubertal and early adolescent bipolar disorder phenotype. Am J Psychiatry 2004;161:1698-1700.
40. Surtees PG, Wainwright NW, Willis-Owen SA, Sandhu MS, et al. No association between the BDNF Val66Met polymorphism and mood status in a non-clinical community sample of 7389 older adults. J Psychiatr Res 2007;41:404-409.
41. Watanabe Y, Muratake T, Kaneko N, Nunokawa A, Someya T. No association between the brain-derived neurotrophic factor gene and schizophrenia in a Japanese population. Schizophr Res 2006;84:29-35.
42. Jablensky A, Sartorius N, Ernberg G, Anker M, et al. Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization tencountry study. Psychol Med Monogr Suppl 1992;20:1-97.
43. Karayiorgou M, Gogos JA. Dissecting the genetic complexity of schizophrenia. Mol Psychiatry 1997;2:211-223.
44. Craddock N O'Donovan MC, Owen MJ. The genetics of schizophrenia and bipolar disorder: dissecting psychosis. J Med Genet 2005;42:193-204.
45. Cardno AG, Gottesman II. Twin studies of schizophrenia: from bow-and-arrow concordances to star wars Mx and functional genomics. Am J Med Genet 2000;97:12-17.
46. McGuffin P, Asherson P, Owen M, Farmer A. The strength of the genetic effect: is there room for an environmental influence in the aetiology of schizophrenia? Br J Med Hypn 1994;164: 593-599.
47. Cannon TD, Kaprio J, Lonnqvist J, Huttunen M, Koskenvuo M. The genetic epidemiology of schizophrenia in a Finnish twin cohort: a population-based modeling study. Arch Gen Psychiatry 1998;55:67-74.
48. Moldin S. Sponsoring initiatives in the molecular genetics of mental disorders. Genetics and mental disorders: Report of the N IMH Genetics Workgroup. Bethesda, MD: National Institues of Health, 1998:559-573.
49. Owen MJ, Craddock N O'Donovan MC. Schizophrenia: genes at last? Trends Genet 2005;21:518-525.
50. Lewis CM, Levinson DF, Wise LH, DeLisi LE, et al. Genome scan meta-analysis of schizophrenia and bipolar disorder. Part II. Schizophrenia. Am J Hum Genet 2003;73:34-48.
51. Berrettini WH. Are schizophrenic and bipolar disorders related? A review of family and molecular studies. Biol Psychiatry 2000;48:531-538.
52. Karayiorgou M, Gogos JA. The molecular genetics of the 22q11-associated schizophrenia. Brain Res Mol Brain Res 2004;132:95-104.
53. Lotta T, Vidgren J, Tilgmann C, Ulmanen I, et al. Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry 1995;34:4202-4210.
54. Egan MF, Goldberg TE, Kolachana BS, Callicott JH, et al. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci USA 2001;98:6917-6922.
55. Malhotra A, Kestler LJ, Mazzanti C, Bates JA, Goldberg T, Goldman D. A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition. Am J Psychiatry 2002;159:652-654.
56. Shifman S, Bronstein M, Sternfeld M, Pisante-Shalom A, et al. A highly significant association between a COMT haplotype and schizophrenia. Am J Hum Genet 2002;71:1296-1302.
57. Glatt SJ, Faraone SV, Tsuang MT. Association between a functional catechol O-methyltransferase gene polymorphism and schizophrenia: meta-analysis of casecontrol and family-based studies. Am J Psychiatry 2003;160:469-476.
58. Jacquet H, Demily C, Houy E, Hecketsweiler B, et al. Hyperprolinemia is a risk factor for schizoaffective disorder. Mol Psychiatry 2005;10:479-485.
59. Gogos JA, Santha M, Takacs Z, Beck KD, et al. The gene encoding proline dehydrogenase modulates sensorimotor gating in mice. Nat Genet 1999;21:434-439.
60. Mukai J, Liu H, Burt RA, Swor DE, et al. Evidence that the gene encoding ZDHHC8 contributes to the risk of schizophrenia. Nat Genet 2004;36:725-731.
61. Glaser B, Schumacher J, Williams HJ, Jamra RA, et al. No association between the putative functional ZDHHC8 single nucleotide polymorphism rs175174 and schizophrenia in large European samples. Biol Psychiatry 2005;58:78-80.
62. Faul T, Gawlik M, Bauer M, Jung S, et al. ZDHHC8 as a candidate gene for schizophrenia: analysis of a putative functional intronic marker in case-control and family-based association studies. BMC Psychiatry 2005;5:35-39.
63. Blackwood DH, Fordyce A, Walker MT, St Clair DM, Porteous DJ, Muir WJ. Schizophrenia and affective disorders-cosegregation with a translocation at chromosome 1q42 that directly disrupts brain-expressed genes: clinical and P300 findings in a family. Am J Hum Genet 2001;69:428-433.
64. Ekelund J, Hovatta I, Parker A, Paunio T, et al. Chromosome 1 loci in Finnish schizophrenia families. Hum Mol Genet 2001;10:1611-1617.
65. Millar JK, James R, Christie S, Porteous DJ. Disrupted in schizophrenia 1 (DISC1): subcellular targeting and induction of ring mitochondria. Mol Cell Neurosci 2005;30:477-484.
66. Miyoshi K, Honda A, Baba K, Taniguchi M, et al. Disrupted-in- schizophrenia 1, a candidate gene for schizophrenia, participates in neurite outgrowth. Mol Psychiatry 2003;8:685-694.
67. Callicott JH, Straub RE, Pezawas L, Egan MF, et al. Variation in DISC1 affects hippocampal structure and function and increases risk for schizophrenia. Proc Natl Acad Sci USA 2005;102:8627-8632.
68. Thomson PA, Harris SE, Starr JM, Whalley LJ, Porteous DJ, Deary IJ. Association between genotype at an exonic SNP in DISC1 and normal cognitive aging. Neurosci Lett 2005;389:41-45.
69. Chen QY, Chen Q, Feng GY, Lindpaintner K, et al. Case-control association study of disrupted-in-schizophrenia-1 (DISC1) gene and schizophrenia in the Chinese population. J Psychiatr Res 2007;41:428-434.
70. Hodgkinson CA, Goldman D, Jaeger J, Persaud S, et al. Disrupted in schizophrenia 1 (DISC1): association with schizophrenia, schizoaffective disorder, and bipolar disorder. Am J Hum Genet 2004;75:862-872.
71. Millar JK, Pickard BS, Mackie S, James R, et al. DISC1 and PDE4B are interacting genetic factors in schizophrenia that regulate cAMP signaling. Science 2005;310:1187-1191.
72. Straub RE, Jiang Y, MacLean CJ, Ma Y, et al. Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. Am J Hum Genet 2002;71:337-348.
73. Talbot K, Eidem WL, Tinsley CL, Benson MA, et al. Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia. J Clin Invest 2004;113:1353-1363.
74. Stefansson H, Sigurdsson E, Steinthorsdottir V, Bjornsdottir S, et al. Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet 2002;71:877-892.
75. Fukui N, Muratake T, Kaneko N, Amagane H, Someta T. Supportive evidence for neuregulin 1 as a susceptibility gene for schizophrenia in a Jamanese population. Neurosci Lett 2006;396:117-120.
76. Li D, Collier DA, He L. Meta-analysis shows strong positive association of the neuregulin 1 (NRG1) gene with schizophrenia. Hum Mol Genet 2006;15:1995-2002.
77. Munafo MR, Thiselton DL, Clark TG, Flint J. Association of the NRG1 gene and schizophrenia: a meta-analysis. Mol Psychiatry 2006;11:539-546.
78. Corfas G, Roy K, Buxbaum JD. Neuregulin 1-erbB signaling and the molecular/ cellular basis of schizophrenia. Nat Neurosci 2004;7:575-580.
79. Lemke G. Neuregulin-1 and myelination. Sci STKE 2006;325:pe11.
80. Stefansson H, Steinthorsdottir V, Thorgeirsson TE, Gulcher JR, Stefansson K. Neuregulin 1 and schizophrenia. Ann Med 2004;36:62-71.
81. Chumakov I, Blumenfeld M, Guerassimenko O, Cavarec L, et al. Genetic and physiological data implicating the new human gene G72 and the gene for Damino acid oxidase in schizophrenia. Proc Natl Acad Sci USA 2002;99:13675-13680.
82. Detera-Wadleigh SD, McMahon FJ. G72/G30 in schizophrenia and bipolar disorder: review and meta-analysis. Biol Psychiatry 2006;60:106-114.
83. Williams NM, Green EK, Macgregor S, Dwyer S, et al. Variation at the DAOA/G30 locus influences susceptibility to major mood episodes but not psychosis in schizophrenia and bipolar disorder. Arch Gen Psychiatry 2006;63:366-373.
84. Berrettini WH, Yoshikawa T, Goldin LR, et al. Evidence for shared susceptibility in bipolar disorder and schizophrenia. Am J Med Genet C Semin Med Genet 2003;123:59-64.
85. Prichard MA, Hackett RP, Erb HN. Long-term outcome of tooth repulsion in horses: a retrospective study of 61 cases. Vet Surg 1992;21:145-149.
86. Williams NM, Preece A, Spurlock G, Norton N, et al. Support for RGS4 as a susceptibility gene for schizophrenia. Biol Psychiatry 2004;55:192-195.
87. Chen X, Dunham C, Kendler S, Wang X, et al. Regulator of G-protein signaling 4 (RGS4) gene is associated with schizophrenia in Irish high density families. Am J Med Genet B Neuropsychiatr Genet 2004;129:23-26.
88. Morris DW, Rodgers A, McGhee KA, Schwaiger S, et al. Confirming RGS4 as a susceptibility gene for schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2004;125:50-53.
89. Rizig MA, McQuillin A, Puri V, Choudhury K, et al. Failure to confirm genetic association between schizophrenia and markers on chromosome 1q23.3 in the region of the gene encoding the regulator of G-protein signaling 4 protein (RGS4). Am J Med Genet B Neuropsychiatr Genet 2006;141:296-300.
90. Davidson JR, Payne VM, Connor KM, Foa EB, et al. Trauma, resilience and saliostasis: effects of treatment in post-traumatic stress disorder. Int Clin Psychopharmacol 2005;20:43-48.
91. Breslau N, Kessler R, Chilcoat H, Schultz L, Davis G, Andreski P. Trauma and posttraumatic stress disorder in the community: the 1996 Detroit Area Survey of Trauma. Arch Gen Psychiatry 1998;55:626-632.
92. Yehuda R, McFarlane A, Shalev A. Predicting the development of postraumatic stress disorder from the acute response to a traumatic event. Biol Psychiatry 1998;44:1305-1313.
93. Shalev AY, Peri T, Canetti L, Schreiber S. Predictors of PTSD in injured trauma survivors: a prospective study. Am J Psychiatry 1996;153:219-225.
94. True WR, Rice J, Eisen SA, Heath AC. A twin study of genetic and environmental contributions to liability for posttraumatic stress symptoms. Arch Gen Psychiatry 1993;50 (4):257-265.
95. Radant A, Tsuang D, Peskind ER, McFall ME, Rasking W. Biological markers and diagnostic accuracy in the genetics of posttraumatic stress disorder. Psychiatry Res 2001;102:203-215.
96. Zhang H, Ozbay F, Lappalainen J, Kranzler HR, et al. Brain derived neurotrophic factor (BDNF) gene variants and Alzheimer's disease, affective disorders, posttraumatic stress disorder, schizophrenia, and substance dependence. Am J Med Genet B Neuropsychiatr Genet 2006;141B:387-393.
97. Young RM, Lawford BR, Noble EP, et al. Harmful drinking in military veterans with post-traumatic stress disorder: association with the D2 dopamine receptor A1 allele. Alcohol Alcohol 2002;37:451-456.
98. Lee HJ, Lee MS, Kang RH, Kim H, et al. Influence of the serotonin transporter promoter gene polymorphism on susceptibility to posttraumatic stress disorder. Depress Anxiety 2005;21:135-139.
99. Gelernter J, Southwick S, Goodson S, Morgan A, Nagy L, Charney DS. No association between D2 dopamine receptor (DRD2) "A" system alleles, or DRD2 haplotypes, and posttraumatic stress disorder. Biol Psychiatry 1999;45:620-625.
100. Lawford BR, Young R, Noble EP, Kann B, Ritchie T. The D2 dopamine receptor (DRD2) gene is associated with co-morbid depression, anxiety and social dysfunction in untreated veterans with post-traumatic stress disorder. Eur Psychiatry 2006;21:180-185.
101. Finn CT, Smoller JW. The genetics of panic disorder. Curr Psychiatry Rep 2001;3:131-137.
102. Hettema JM, Neale MC, Kendler KS. A review and meta-analysis of the genetic epidemiology of anxiety disorders. Am J Psychiatry 2001;158:1568-1578.
103. Scherrer JF, True WR, Xian H, Lyons MJ, et al. Evidence for genetic influences common and specific to symptoms of generalized anxiety and panic. J Affect Disord 2000;57:25-35.
104. Merikangas KR, Low NC. Genetic epidemiology of anxiety disorders. Handb Exp Pharmacol 2005 169:163-179.
105. Skre I, Onstad S, Torgersen S, Lygren S, Kringlen E. A twin study of DSM-III-R anxiety disorders. Acta Psychiatr Scand 1993;88:85-92.
106. Hettema JM, Kuhn JW, Prescott CA, Kendler KS. The impact of generalized anxiety disorder and stressful life events on risk for major depressive episodes. Psychol Med 2006;36:789-795.
107. Kendler KS, Neale MC, Kessler RC, Heath AC, Eaves LJ. Generalized anxiety disorder in women: a population-based twin study. Arch Gen Psychiatry 1992;49:267-272.
108. Cloninger CR, Van Eerdewegh P, Goate A, Edenberg HJ, et al. Anxiety proneness linked to epistatic loci in genome scan of human personality traits. Am J Med Genet 1998;81:313-317.
109. Sen S, Burmeister M, Ghosh D. Meta-analysis of the association between a serotonin transporter promoter polymorphism (5-HTTLPR) and anxiety-related personality traits. Am J Med Genet B Neuropsychiatr Genet 2004;127:85-89.
110. Mazzanti CM, Lappalainen J, Long JC, Bengel D, et al. Role of the serotonin transporter promoter polymorphism in anxiety-related traits. Arch Gen Psychiatry 1998;55:936-940.
111. Savitz JB, Ramesar RS. Genetic variants implicated in personality: a review of the more promising candidates. Am J Med Genet B Neuropsychiatr Genet 2004;131:20-32.
112. Jonnal AH, Gardner CO, Prescott CA, Kendler KS. Obsessive and compulsive symptoms in a general population sample of female twins. Am J Med Genet 2000;96:791-796.
113. Grados MA, Walkup J, Walford S. Genetics of obsessive-compulsive disorders: new findings and challenges. Brain Dev 2003;25:S55-S61.
114. Hanna GL, Veenstra-VanderWeele J, Cox NJ, Boehnke M, et al. Genome-wide linkage analysis of families with obsessive-compulsive disorder ascertained through pediatric probands. Am J Med Genet 2002;114:541-552.
115. Cuker A, State MW, King RA, Davis N, Ward DC. Candidate locus for Gilles de la Tourette syndrome/obsessive compulsive disorder/chronic tic disorder at 18q22. Am J Med Genet A 2004;130:37-39.
116. Nurnberger JIJ, Wiegand R, Bucholz K, et al. A family study of alcohol dependence: coaggregation of multiple disorders in relatives of alcohol-dependent probands. Arch Gen Psychiatry 2004;61:1246-1256.
117. Saxon AJ, Oreskovich MR, Brkanac Z. Genetic determinants of addiction to opioids and cocaine. Harv Rev Psychiatry 2005;13:218-232.
118. Sullivan PF, Kendler KS. The genetic epidemiology of smoking. Nicotine Tob Res 1999;1:51-57.
119. Uhl GR, Liu QR, Naiman D. Substance abuse vulnerability loci: converging genome scanning data. Trends Genet 2002;18:420-405.
120. Horowitz R, Kotler M, Shufman E, Aharoni S, et al. Confirmation of an excess of the high enzyme activity COMT val allele in heroin addicts in a family-based haplotype relative risk study. Am J Med Genet 2000;96:599-603.
121. Vandenbergh DJ, Rodriguez LA, Miller IT, Uhl GR, Lachman HM. High-activity catechol-O-methyltransferase allele is more prevalent in polysubstance abusers. Am J Med Genet 1997;74:439-442.
122. Uhl GR, Vandenbergh DJ, Rodriguez LA, Miner L, Takahashi N. Dopaminergic genes and substance abuse. Adv Pharmacol 1998;42:1024-1032.
123. Bookheimer SY, Strojwas MH, Cohen MS, Saunders AM, et al. Patterns of brain activation in people at risk for Alzheimer's disease. N Engl J Med 2000;343:502-503.
124. Beyer JL, Krishnan KR. Volumetric brain imaging findings in mood disorders. Bipolar Disord 2002;4:89-104.
125. Brambilla P, Barale F, Caverzasi E, Soares JC. Anatomical MRI findings in mood and anxiety disorders. Epidemiol Psichiatr Soc 2002;11:88-99.
126. Rochfort S. Metabolomics reviewed: a new "omics" platform technology for systems biology and implications for natural products research. J Nat Prod 2005;68:1813-1820.
127. Prabakaran S, Swatton JE, Ryan MM, Huffaker SJ, et al. Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Mol Psychiatry 2004;9:684-697.
128. Liu ET, Kuznetsov VA, Miller LD. In the pursuit of complexity: systems medicine in cancer biology. Cancer Cell 2006;9:245-247.
129. Lunshof J. Teaching and practicing pharmacogenomics: a complex matter. Pharmacogenomics 2006;7:243-246.
130. Butcher EC, Berg EL, Kunkel EJ. Systems biology in drug discovery. Nat Biotechnol 2004;22:626-632.